Clinical Trial Update: Biomarkers for Risk Stratification in Lung Cancer

View source ↗

Summary

Ongoing clinical trial update focusing on biomarkers for risk stratification in lung cancer, with recruitment for solitary pulmonary nodule and non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solitary Pulmonary Nodule

Snippet

Sponsor: University of California, San Francisco | Conditions: Nodule Solitary Pulmonary, Non-small Cell Lung Cancer | Status: RECRUITING